Skip to Content

VIDEO: Open Orphan’s Cathal Friel on firm’s ambitious plans in the coronavirus vaccination space

Open Orphan

In the video below, provided by piworld, Cathal Friel, executive director of Open Orphan (LSE:ORPH) give a presentation to members of ShareSoc at the organisation’s latest Growth Company webinar.

Among other subjects, Friel runs through Open Orphan’s word-first coronavirus challenge model, its subsidiary hVIVO, its vaccine and pharmaceutical portfolio, and its genomic data capturing capabilities.Open Orphan is a European-focussed, rare and orphan drug consulting services platform with four key focuses: European clinical research; orphan drug services; a Virtual Rep and Data Access platform; and a Health Data Platform to partner with Patient Advocacy Groups.

piworld provides content for investors, by investors.

The organisation aims to help private investors get closer to companies and their management and – in turn – make more informed investment decisions.

Videos include:

•             Company results presentations

•             Management interviews

•             Company visits

•             Enlightened educational investor videos with investors, opinion formers, and industry leaders

Related Articles


teathers app screenshot

App Empowering Private Investors

Crowd Equity for Placings, IPOs and Live Market Blockbuilds, designed to give provate investors access to placements and Intial Public Offerings (IPOs), predominantly on the London Stock Exchange’s Alternative Investment Market (AIM).